Next Article in Journal
The Dual Lens of Endoscopy and Histology in the Diagnosis and Management of Eosinophilic Gastrointestinal Disorders—A Comprehensive Review
Next Article in Special Issue
Abnormal Static Sagittal Cervical Curvatures following Motor Vehicle Collisions: A Retrospective Case Series of 41 Patients before and after a Crash Exposure
Previous Article in Journal
Breaking Sound Barriers: Exploring Tele-Audiology’s Impact on Hearing Healthcare
Previous Article in Special Issue
MR-Imaging in Osteoarthritis: Current Standard of Practice and Future Outlook
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Interesting Images

Myxofibrosarcoma of the Chest Wall Detected on 99mTc-MDP Whole-Body Bone Scan

by
Chia-Hsuan Lee
1,2,
Hueng-Yuan (Daniel) Shen
1,
Yow-Ling (Shirley) Shiue
3,4,
Hung-Yen Chan
1 and
Hung-Pin Chan
1,3,*
1
Department of Nuclear Medicine, Kaohsiung Veterans General Hospital, Kaohsiung City 813, Taiwan
2
Department of Psychiatry, Kaohsiung Medical University Hospital, Kaohsiung City 807, Taiwan
3
Institute of Biomedical Sciences, College of Medicine, National Sun Yat-sen University, Kaohsiung City 804, Taiwan
4
Institute of Precision Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung City 804, Taiwan
*
Author to whom correspondence should be addressed.
Diagnostics 2024, 14(8), 857; https://doi.org/10.3390/diagnostics14080857
Submission received: 17 March 2024 / Revised: 15 April 2024 / Accepted: 18 April 2024 / Published: 22 April 2024
(This article belongs to the Special Issue Imaging Diagnosis in Musculoskeletal Medicine)

Abstract

:
Myxofibrosarcoma is a type of soft tissue sarcoma, predominantly characterized by a high propensity for local recurrence, albeit demonstrating a relatively diminished risk for distant metastasis. Its prevalence is notably higher in elderly patients. Here, we present a case of a 73-year-old woman diagnosed with Myxofibrosarcoma. She was subjected to a whole-body bone scan using 99mTc-methylene diphosphonate (MDP) to survey potential bony metastasis. It revealed marked MDP accumulation with peripheral soft tissue uptake in the right lateral chest region of this patient. This imaging phenotype could potentially be attributed to the augmented vascularity within the tumor, a finding that was prominently displayed in this particular case.

Figure 1. A 73-year-old woman presented with an enlarging mass over the right posterior and lateral upper trunk regions, and also complained of right upper limb weakness. An incisional biopsy of the tumor was performed, and the pathology report identified the mass as a high-grade myxofibrosarcoma (MFS). Given her symptoms, a 99mTc-methylene diphosphonate (MDP) whole-body bone scan (WBBS) was arranged by a physician to survey for bony metastasis. The scan revealed a protruding soft tissue lesion in the lateral right chest region, with increased MDP uptake in the inferior aspect ((A), red arrow), and two MDP-avid foci in the area of the right 5th-6th ribs ((B), white arrows). A malposition of the right kidney was incidentally found. A chest CT scan revealed a large 6 × 9 × 12 cm protruding mass at the right chest wall with peripheral contrast enhancement with a central cystic-like component/multilobulated configuration ((C), red arrowhead), corresponding to the MDP uptake seen on the WBBS. It also shows invasion of the right 5th-6th intercostal muscles, but no invasion of the right 5th-6th ribs, contrary to what the WBBS was suggesting ((D), white arrowheads). There are no obvious osteolytic or osteoblastic lesions within the scan field of the CT. However, lung metastasis is also noted on the chest CT ((E), green arrow), leading to the arrangement of neo-adjuvant chemotherapy as the initial treatment. After six months, disease progression was noted, with multiple liver metastases. MFS typically arises in elderly patients, most commonly in the lower extremities, followed by the trunk. It is known to have a higher local recurrence rate (about 15~48%) but a relatively lower risk of distant metastases (near 10%) among soft-tissue tumors [1]. The treatment of MFS may involve a combination of surgical resection, radiation, chemotherapy, or targeted therapy, depending on the tumor status [2]. MRI or CT can play a crucial role in diagnosis and preoperative planning. In the literature, MFS has been reported for the detection of local tumor recurrence or metastasis using thallium-201 or FDG PET [3,4,5,6]. In our case, the MDP-avid tumor uptake and peripheral contrast enhancement/multilobulated configuration of the tumor may be related to an abundance of blood flow to the tumor. The WBBS also showed MDP-avid intercostal muscle invasion. A published article on MRI noted a multilobulated configuration of soft-tissue sarcoma, which correlates with the malignancy grade [7]. This configuration may be compatible with the biopsy results of this case. This case exemplifies the critical role of multimodal imaging in the diagnosis of myxofibrosarcoma, particularly in assessing tumor vascularity and morphology. It not only contributes to the existing literature by detailing a less common site and presentation of myxofibrosarcoma but also underscores the importance of an integrated approach to oncologic imaging in planning further treatments.
Figure 1. A 73-year-old woman presented with an enlarging mass over the right posterior and lateral upper trunk regions, and also complained of right upper limb weakness. An incisional biopsy of the tumor was performed, and the pathology report identified the mass as a high-grade myxofibrosarcoma (MFS). Given her symptoms, a 99mTc-methylene diphosphonate (MDP) whole-body bone scan (WBBS) was arranged by a physician to survey for bony metastasis. The scan revealed a protruding soft tissue lesion in the lateral right chest region, with increased MDP uptake in the inferior aspect ((A), red arrow), and two MDP-avid foci in the area of the right 5th-6th ribs ((B), white arrows). A malposition of the right kidney was incidentally found. A chest CT scan revealed a large 6 × 9 × 12 cm protruding mass at the right chest wall with peripheral contrast enhancement with a central cystic-like component/multilobulated configuration ((C), red arrowhead), corresponding to the MDP uptake seen on the WBBS. It also shows invasion of the right 5th-6th intercostal muscles, but no invasion of the right 5th-6th ribs, contrary to what the WBBS was suggesting ((D), white arrowheads). There are no obvious osteolytic or osteoblastic lesions within the scan field of the CT. However, lung metastasis is also noted on the chest CT ((E), green arrow), leading to the arrangement of neo-adjuvant chemotherapy as the initial treatment. After six months, disease progression was noted, with multiple liver metastases. MFS typically arises in elderly patients, most commonly in the lower extremities, followed by the trunk. It is known to have a higher local recurrence rate (about 15~48%) but a relatively lower risk of distant metastases (near 10%) among soft-tissue tumors [1]. The treatment of MFS may involve a combination of surgical resection, radiation, chemotherapy, or targeted therapy, depending on the tumor status [2]. MRI or CT can play a crucial role in diagnosis and preoperative planning. In the literature, MFS has been reported for the detection of local tumor recurrence or metastasis using thallium-201 or FDG PET [3,4,5,6]. In our case, the MDP-avid tumor uptake and peripheral contrast enhancement/multilobulated configuration of the tumor may be related to an abundance of blood flow to the tumor. The WBBS also showed MDP-avid intercostal muscle invasion. A published article on MRI noted a multilobulated configuration of soft-tissue sarcoma, which correlates with the malignancy grade [7]. This configuration may be compatible with the biopsy results of this case. This case exemplifies the critical role of multimodal imaging in the diagnosis of myxofibrosarcoma, particularly in assessing tumor vascularity and morphology. It not only contributes to the existing literature by detailing a less common site and presentation of myxofibrosarcoma but also underscores the importance of an integrated approach to oncologic imaging in planning further treatments.
Diagnostics 14 00857 g001

Author Contributions

Writing—original draft preparation, C.-H.L. and H.-P.C.; Writing—review and editing, H.-Y.S. and Y.-L.S. Image analysis, H.-Y.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Ethical review and approval were waived for this report due to its retrospective case description, which did not impact the management of the patient.

Informed Consent Statement

Written informed consent has been obtained to publish this paper.

Data Availability Statement

The original data presented in the study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Spinnato, P.; Sambri, A.; Fujiwara, T.; Ceccarelli, L.; Clinca, R.; Medellin, M.R.; Paolis, M.D.; Donati, D.M.; Bianchi, G. Myxofibrosarcoma: Clinical and Prognostic Value of MRI Features. Curr. Med. Imaging 2021, 17, 217–224. [Google Scholar] [CrossRef] [PubMed]
  2. Vanni, S.; De Vita, A.; Gurrieri, L.; Fausti, V.; Miserocchi, G.; Spadazzi, C.; Liverani, C.; Cocchi, C.; Calabrese, C.; Bongiovanni, A.; et al. Myxofibrosarcoma landscape: Diagnostic pitfalls, clinical management and future perspectives. Ther. Adv. Med. Oncol. 2022, 28, 17588359221093973. [Google Scholar] [CrossRef] [PubMed]
  3. Wu, Y.C.; Hsieh, T.C.; Kao, C.H.; Hsieh, C.Y.; Lin, T.Y.; Wang, C.H.; Lin, Y.Y.; Yen, K.Y.; Sun, S.S. Thallium-201 scintigraphy of myxofibrosarcoma. Clin. Nucl. Med. 2009, 34, 943–945. [Google Scholar] [CrossRef] [PubMed]
  4. Enomoto, K.; Inohara, H.; Hamada, K.; Tamura, M.; Tomita, Y.; Kubo, T.; Hatazawa, J. FDG PET imaging of myxofibrosarcoma on the sphenoid sinus. Clin. Nucl. Med. 2008, 33, 421–422. [Google Scholar] [CrossRef] [PubMed]
  5. Ito, K.; Masuda-Miyata, Y.; Wada, S.; Morooka, M.; Yamasawa, K.; Hashimoto, M.; Kubota, K. F-18 FDG PET/CT imaging of bulky myxofibrosarcoma in chest wall. Clin. Nucl. Med. 2011, 36, 212–213. [Google Scholar] [CrossRef] [PubMed]
  6. Erdoğan, E.B.; Asa, S.; Aksoy, S.Y.; Ozhan, M.; Halac, M. Appearance of recurrent cardiac myxofibrosarcoma on FDG PET/CT. Clin. Nucl. Med. 2014, 39, 559–560. [Google Scholar] [CrossRef] [PubMed]
  7. Sedaghat, S.; Salehi Ravesh, M.; Sedaghat, M.; Both, M.; Jansen, O. Configuration of soft-tissue sarcoma on MRI correlates with grade of malignancy. Radiol. Oncol. 2021, 55, 158–163. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lee, C.-H.; Shen, H.-Y.; Shiue, Y.-L.; Chan, H.-Y.; Chan, H.-P. Myxofibrosarcoma of the Chest Wall Detected on 99mTc-MDP Whole-Body Bone Scan. Diagnostics 2024, 14, 857. https://doi.org/10.3390/diagnostics14080857

AMA Style

Lee C-H, Shen H-Y, Shiue Y-L, Chan H-Y, Chan H-P. Myxofibrosarcoma of the Chest Wall Detected on 99mTc-MDP Whole-Body Bone Scan. Diagnostics. 2024; 14(8):857. https://doi.org/10.3390/diagnostics14080857

Chicago/Turabian Style

Lee, Chia-Hsuan, Hueng-Yuan (Daniel) Shen, Yow-Ling (Shirley) Shiue, Hung-Yen Chan, and Hung-Pin Chan. 2024. "Myxofibrosarcoma of the Chest Wall Detected on 99mTc-MDP Whole-Body Bone Scan" Diagnostics 14, no. 8: 857. https://doi.org/10.3390/diagnostics14080857

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop